Inventor
SOUERS ANDREW
US11 patents
Patents
11 patentsUS8940737B2Jan 27, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC7 citations83
US9345702B2May 24, 2016
Methods of treatment using selective Bcl-2 inhibitors
ABBVIE INC8 citations81
US11786519B2Oct 17, 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9844547B2Dec 19, 2017
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations62
US9266877B2Feb 23, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US8889675B2Nov 18, 2014
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC3 citations62
US9877958B2Jan 30, 2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations51
US10081628B2Sep 25, 2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations50
US9872861B2Jan 23, 2018
Methods of treatment using selective Bcl-2 inhibitors
ABBVIE INC1 citations49
US9328112B2May 3, 2016
Tetracyclic CDK9 kinase inhibitors
ABBVIE INC0 citations39
US9796708B2Oct 24, 2017
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors
ABBVIE INC0 citations36